FAYZX | RLBEX | FAYZX / RLBEX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 9 years | 22 years | - |
Gain YTD | 11.189 | 14.028 | 80% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.82B | 236B | 1% |
Annual Yield % from dividends | 4.02 | 2.24 | 180% |
Returns for 1 year | 17.29 | 20.89 | 83% |
Returns for 3 years | 7.44 | 10.45 | 71% |
Returns for 5 years | 52.16 | 35.63 | 146% |
Returns for 10 years | N/A | 52.55 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FLUEX | 28.90 | -0.06 | -0.21% |
Fidelity Advisor Stk Selec Lg Cp Val C | |||
MIEFX | 13.35 | -0.07 | -0.52% |
Matthews Emerging Markets Equity Ins | |||
JHURX | 29.71 | -0.23 | -0.77% |
JPMorgan Emerging Markets Equity R3 | |||
VSFSX | 27.93 | -0.28 | -0.99% |
Federated Hermes Clover Small Value R6 | |||
PCHSX | 34.88 | -0.72 | -2.02% |
Putnam Global Health Care C |